- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 30.89 | -28.86 | 17.23 | 0 | 0 | 0 | 6.69 | 29.15 | 58.53 | 0 | 0 | 0 | 0.00 | 0 | 0 | 21.66 | 81.54 | 35.23 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 24Q2 (19) | 43.42 | -38.46 | 10.34 | 0 | 0 | 0 | 5.18 | -3.36 | 23.92 | 0 | 0 | 0 | 0.00 | 0 | 0 | 11.93 | 57.05 | 12.31 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 24Q1 (18) | 70.56 | 16.9 | 145.34 | 0 | 0 | 0 | 5.36 | 1.71 | 27.32 | 0 | 0 | 0 | 0.00 | 0 | 0 | 7.60 | -12.99 | -48.11 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q4 (17) | 60.36 | 129.07 | -31.55 | 0 | 0 | 0 | 5.27 | 24.88 | -41.96 | 0 | 0 | 0 | 0.00 | 0 | 0 | 8.73 | -45.48 | -15.21 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q3 (16) | 26.35 | -33.04 | -42.4 | 0 | 0 | 0 | 4.22 | 0.96 | -15.26 | 0 | 0 | 0 | 0.00 | 0 | 0 | 16.02 | 50.76 | 47.13 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q2 (15) | 39.35 | 36.82 | 67.16 | 0 | 0 | 0 | 4.18 | -0.71 | -7.11 | 0 | 0 | 0 | 0.00 | 0 | 0 | 10.62 | -27.43 | -44.43 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q1 (14) | 28.76 | -67.38 | 175.22 | 0 | 0 | 0 | 4.21 | -53.63 | -5.82 | 0 | 0 | 0 | 0.00 | 0 | 0 | 14.64 | 42.16 | -65.78 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 22Q4 (13) | 88.18 | 92.74 | 45.42 | 0 | 0 | 0 | 9.08 | 82.33 | 75.63 | 0 | 0 | 0 | 0.00 | 0 | 0 | 10.30 | -5.4 | 20.78 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
| 22Q3 (12) | 45.75 | 94.35 | 87.19 | 0 | 0 | 0 | 4.98 | 10.67 | 10.67 | 0 | 0 | 0 | 0.00 | 0 | 0 | 10.89 | -43.06 | -40.88 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
| 22Q2 (11) | 23.54 | 125.26 | 94.87 | 0 | 0 | 0 | 4.5 | 0.67 | 12.78 | 0 | 0 | 0 | 0.00 | 0 | 0 | 19.12 | -55.31 | -42.12 | 0.00 | 0 | 0 | 0 | 0 | -100.0 |
| 22Q1 (10) | 10.45 | -82.77 | -62.14 | 0 | 0 | 0 | 4.47 | -13.54 | -6.68 | 0 | 0 | 0 | 0.00 | 0 | 0 | 42.78 | 401.72 | 146.47 | 0.00 | 0 | 0 | 0 | -100.0 | -100.0 |
| 21Q4 (9) | 60.64 | 148.12 | -25.61 | 0 | 0 | 0 | 5.17 | 14.89 | -3.54 | 0 | 0 | 0 | 0.00 | 0 | 0 | 8.53 | -53.7 | 29.67 | 0.00 | 0 | 0 | 913 | 0.0 | 0.0 |
| 21Q3 (8) | 24.44 | 102.32 | -16.13 | 0 | 0 | 0 | 4.5 | 12.78 | 18.73 | 0 | 0 | 0 | 0.00 | 0 | 0 | 18.41 | -44.26 | 41.57 | 0.00 | 0 | 0 | 913 | 0.0 | 0.0 |
| 21Q2 (7) | 12.08 | -56.23 | -41.53 | 0 | 0 | 0 | 3.99 | -16.7 | 17.7 | 0 | 0 | 0 | 0.00 | 0 | 0 | 33.03 | 90.32 | 101.3 | 0.00 | 0 | 0 | 913 | 0.0 | 0.0 |
| 21Q1 (6) | 27.6 | -66.14 | 228.18 | 0 | 0 | 0 | 4.79 | -10.63 | 35.31 | 0 | 0 | 0 | 0.00 | 0 | 0 | 17.36 | 163.95 | -58.77 | 0.00 | 0 | 0 | 913 | 0.0 | 0.0 |
| 20Q4 (5) | 81.52 | 179.75 | 60.22 | 0 | 0 | 0 | 5.36 | 41.42 | 13.08 | 0 | 0 | 0 | 0.00 | 0 | 0 | 6.58 | -49.45 | -29.42 | 0.00 | 0 | 0 | 913 | 0.0 | 0.0 |
| 20Q3 (4) | 29.14 | 41.05 | 0.0 | 0 | 0 | 0.0 | 3.79 | 11.8 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 13.01 | -20.74 | 0.0 | 0.00 | 0 | 0.0 | 913 | 0.0 | 0.0 |
| 20Q2 (3) | 20.66 | 145.66 | 0.0 | 0 | 0 | 0.0 | 3.39 | -4.24 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 16.41 | -61.02 | 0.0 | 0.00 | 0 | 0.0 | 913 | 0.0 | 0.0 |
| 20Q1 (2) | 8.41 | -83.47 | 0.0 | 0 | 0 | 0.0 | 3.54 | -25.32 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 42.09 | 351.83 | 0.0 | 0.00 | 0 | 0.0 | 913 | 0.0 | 0.0 |
| 19Q4 (1) | 50.88 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 4.74 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 9.32 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 913 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 154.81 | -7.81 | 0 | 0 | 17.88 | -22.36 | 0 | 0 | 0.00 | 0 | 11.55 | -15.79 | 0.00 | 0 | 0 | 0 |
| 2022 (9) | 167.92 | 34.59 | 0 | 0 | 23.03 | 24.82 | 0 | 0 | 0.00 | 0 | 13.71 | -7.26 | 0.00 | 0 | 0 | 0 |
| 2021 (8) | 124.76 | -10.72 | 0 | 0 | 18.45 | 14.81 | 0 | 0 | 0.00 | 0 | 14.79 | 28.6 | 0.00 | 0 | 913 | 0.0 |
| 2020 (7) | 139.74 | 20.22 | 0 | 0 | 16.07 | -3.37 | 0 | 0 | 0.00 | 0 | 11.50 | -19.62 | 0.00 | 0 | 913 | 0.0 |
| 2019 (6) | 116.24 | -18.68 | 0 | 0 | 16.63 | 11.99 | 0 | 0 | 0.00 | 0 | 14.31 | 37.72 | 0.00 | 0 | 913 | 0.0 |
| 2018 (5) | 142.95 | 16.5 | 0 | 0 | 14.85 | 19.28 | 0 | 0 | 0.00 | 0 | 10.39 | 2.38 | 0.00 | 0 | 913 | 0.0 |
| 2017 (4) | 122.7 | -34.37 | 0 | 0 | 12.45 | 0 | 0 | 0 | 0.00 | 0 | 10.15 | 0 | 0.00 | 0 | 913 | 0.0 |
| 2016 (3) | 186.96 | 89.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 913 | 2.47 |
| 2015 (2) | 98.48 | -0.44 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 891 | 52.57 |
| 2014 (1) | 98.92 | 21.51 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 584 | 192.0 |
